In order to foster innovation and to develop novel synthetic biology solutions, Agilent technologies have recently collaborated with Transcriptic.
Transcriptic's automated discovery biology enables scalable life science research through a convenient and simple web interface.
This platform can be used by biologists to control their science and generate data remotely via the cloud.
This collaboration will add multiple Agilent Genomics product lines for mutagenesis and cloning to the protocol library within the Transcriptic robotic cloud laboratory like QuikChange Lightning which will accelerate the generation of multiple mutants for large protein function projects and providing cutting-edge Agilent bioreagents in a robotic laboratory setting allowing a global customer base to automate and optimize workflows for rapid and efficient research discoveries.
Commenting on the same, Herman Verrelst, Agilent Vice president and General Manager of the company's Genomics Solutions Division and Clinical Applications Division said, "We're excited to combine our genome engineering tools with automated experimentation. Transcriptic's services are validated, scalable, and accessible from anywhere in the world, which will enhance the market for our industry-leading reagents.
Yvonne Linney, chief operating officer at Transcriptic said, "By bringing these products to Transcriptic, we will make it extremely easy for customers to scale up their research, using many mutants to produce very large datasets for exploring protein function."